Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
• European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
• New Data Support Routine Childhood Vaccination With PREVENAR in Europe
• Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
• Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
• Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
• Sanofi Aventis : New Study Results Support the"Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
• New Published Data Support Safety and Efficacy of RESOLOR(R) for Treatment of Chronic Constipation
• Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
• European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment

politikportal.at: das APA-OTS-Portal für multimediale Presse ...

politikportal.at: das APA OTS-Portal für multimediale Presse More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL

Bankkaufmann - News

Auf dieser Seite finden Sie Neuigkeiten zum Thema: Aktuelle More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL

Presseportal: Meldung versenden

More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL E-Mail-Adresse des Empfängers: Sie können max.5 Empfänger angeben.

More Clinical Data Required to Support European Approval of CAP ...

More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL its application for an extension to the European Marketing